These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2725861)

  • 1. Aluminum-induced neurofibrillary degeneration affects a subset of neurons in rabbit cerebral cortex, basal forebrain and upper brainstem.
    Kowall NW; Pendlebury WW; Kessler JB; Perl DP; Beal MF
    Neuroscience; 1989; 29(2):329-37. PubMed ID: 2725861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits.
    Beal MF; Mazurek MF; Ellison DW; Kowall NW; Solomon PR; Pendlebury WW
    Neuroscience; 1989; 29(2):339-46. PubMed ID: 2566953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibrillary degeneration and neuronal loss in Alzheimer's disease.
    Bondareff W; Mountjoy CQ; Roth M; Hauser DL
    Neurobiol Aging; 1989; 10(6):709-15. PubMed ID: 2628782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity.
    Scholtz CL; Swash M; Gray A; Kogeorgos J; Marsh F
    Clin Neuropathol; 1987; 6(3):93-7. PubMed ID: 3608291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex.
    German DC; White CL; Sparkman DR
    Neuroscience; 1987 May; 21(2):305-12. PubMed ID: 3302759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
    Hof PR; Cox K; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease.
    Morrison JH; Lewis DA; Campbell MJ; Huntley GW; Benson DL; Bouras C
    Brain Res; 1987 Jul; 416(2):331-6. PubMed ID: 3113670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
    Savory J; Huang Y; Wills MR; Herman MM
    Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease.
    Ihara Y
    Brain Res; 1988 Aug; 459(1):138-44. PubMed ID: 3139259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
    Rasool CG; Svendsen CN; Selkoe DJ
    Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles.
    Cruz-Sanchez FF; Rossi ML; Cardozo A; Deacon P; Tolosa E
    Neurosci Lett; 1992 Feb; 136(1):43-6. PubMed ID: 1321966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles.
    Munoz-Garcia D; Pendlebury WW; Kessler JB; Perl DP
    Acta Neuropathol; 1986; 70(3-4):243-8. PubMed ID: 3532685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of aluminum Alzheimer's disease, and neurofibrillary tangles.
    Perl DP; Good PF
    J Neural Transm Suppl; 1987; 24():205-11. PubMed ID: 3316495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
    Shortridge BA; Vogel FS; Burger PC
    Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum neurotoxicity--potential role in the pathogenesis of neurofibrillary tangle formation.
    Perl DP; Pendlebury WW
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):441-5. PubMed ID: 3791060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum.
    Troncoso JC; Sternberger NH; Sternberger LA; Hoffman PN; Price DL
    Brain Res; 1986 Feb; 364(2):295-300. PubMed ID: 3512034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex.
    Quigley BJ; Kowall NW
    Neuroscience; 1991; 41(1):41-60. PubMed ID: 1711654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates.
    Huang Y; Herman MM; Liu J; Katsetos CD; Wills MR; Savory J
    Brain Res; 1997 Oct; 771(2):213-20. PubMed ID: 9401741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?
    Savory J; Exley C; Forbes WF; Huang Y; Joshi JG; Kruck T; McLachlan DR; Wakayama I
    J Toxicol Environ Health; 1996 Aug; 48(6):615-35. PubMed ID: 8772802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary tangles in the cerebral cortex of sheep.
    Nelson PT; Greenberg SG; Saper CB
    Neurosci Lett; 1994 Mar; 170(1):187-90. PubMed ID: 8041504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.